Navigation Links
Corthera's Relaxin Receives FDA Fast Track Designation for the Treatment of Acute Heart Failure
Date:10/1/2009

SAN MATEO' Calif.' Oct. 1 /PRNewswire/ -- Corthera Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to relaxin, the company's investigational drug for the treatment of acute heart failure (AHF). The Fast Track program facilitates the development and expedites the review of new drugs intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs.

"Fast Track designation for the relaxin heart failure program is an important acknowledgement by the FDA of the need for advancements in the treatment of AHF," said Stan Abel, CEO of Corthera. "We are excited to be launching Phase 3 given our goal of advancing the development of relaxin as rapidly as possible for the benefit of patients who are in need of new treatment options."

Corthera's completed Pre-RELAX-AHF study is the Phase 2 portion of a Phase 2/3, multicenter, randomized, double-blind, placebo-controlled, parallel-group, international trial designed to evaluate the efficacy and safety of relaxin for the treatment of AHF. In Pre-RELAX-AHF, the objective was proof-of-concept and dose and endpoint selection. Data from the Phase 2 study were presented at the American College of Cardiology conference earlier this year and published in the medical journal, The Lancet. These data from 234 patients in eight countries showed that when administered with standard-of-care therapy for AHF, patients receiving relaxin had greater and longer-lasting relief of dyspnea (shortness of breath). Relaxin treatment was associated with consistent trends in improvement of the hospital course of patients, prevention of heart failure worsening during hospitalization, shortening of in hospital stay and improved longer-term outcomes following discharge when compared to placebo. Corthera is currently initiating enrollment in the Phase 3 RELAX-AHF study, the objective of which is to confirm the p
'/>"/>

SOURCE Corthera Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Results and Additional Analyses From Study Show That Cortheras Relaxin for Acute Heart Failure is the Strongest Predictor of Improved Longer-Term Outcomes Following Hospital Discharge When Compared to Other Variables
2. Results and Additional Analyses From Efficacy and Safety Study of Cortheras Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009
3. Results From Study Show Promising Efficacy and Safety Results for Cortheras Relaxin in Acute Heart Failure
4. Results From Efficacy and Safety Study of Cortheras Relaxin in Acute Heart Failure to be Presented at Late-Breaking Clinical Trials Session at ACC 58th Annual Scientific Session
5. Corthera Initiates Phase II Clinical Trial of Relaxin in Acute Heart Failure
6. Sigma-Aldrich(R) Receives Award From Michael J. Fox Foundation to Develop Parkinsons Disease Research Models
7. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
8. GenVec Receives National Cancer Institute Grant to Expand Cancer Program
9. Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager
10. Oxygen Biotherapeutics, Inc. Receives Phase II Trial Approval in Israel
11. Childrens Hospital Receives Six-Year Federal Contract to Study Antibiotic Use in Children With Urinary Tract Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014 Soligenix, ... late-stage biopharmaceutical company developing products that address unmet ... and biodefense, announced today that on December 24, ... offering. The Company raised approximately $2.3 ... intends to use the net proceeds from the ...
(Date:12/24/2014)... FLINT, Mich. , Dec. 24, 2014  Diplomat ... largest independent specialty pharmacy, is proud to announce ... and quality at Diplomat, will take office as the ... 2015. The formal induction ceremony will take place Feb. ... which will be held at the Renaissance Center in ...
(Date:12/24/2014)... , Dec. 23, 2014 PuraMed BioScience®, ... of over-the-counter (OTC) medicinal and healthcare products, announced it ... MigraPure® H, a hemp-based, advanced headache relief product, for ... in Colorado , Washington ... With the MigraPure H Advanced headache relief ...
Breaking Medicine Technology:Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3
... & Melinda Gates Foundation today announced that Dr. Trevor Mundel ... Mundel, who is currently global head of development for Novartis ... work at the foundation on December 1. "We ... our global health program," said Bill Gates, co-chair of the ...
... Inc. is pleased to announce its exclusive agreement with ... automated FIT product, a fecal occult blood analyzer that ... the early detection of colorectal cancer. The agreement includes ... and OC-Sensor Diana, a high throughput automated FIT analyzer, ...
Cached Medicine Technology:Gates Foundation Names Dr. Trevor Mundel to Lead Global Health Program 2Polymedco, Inc., and Cardinal Health Sign Agreement for Distribution of Oncologic Diagnostic Test Kits to Acute Care Market 2
(Date:12/25/2014)... (PRWEB) December 26, 2014 Recently, Dylan ... dresses, has excitedly released its collection of discounted prom ... to Percy, a senior spokesman of the company, the ... of this promotion is to expand the UK market. ... in several different colors, lengths, and styles: A-line strapless, ...
(Date:12/25/2014)... December 25, 2014 BambooFlooringChina.com sells many ... quality bamboo flooring. Today, the company announces big ... many styles and colors. , BambooFlooringChina.com is the world’s ... the promotion is valid until Jan. 20, 2015. , ... and woven with a natural thread. All the bamboo ...
(Date:12/25/2014)... Recently, LunaDress.co.uk has updated its blog to provide ... Now, all of the models at LunaDress.co.uk come with big discounts, ... the wedding veil can turn out to be a most exciting ... veil can always bring surprise to a wedding. On the updated ... choose veils for a big day . , Going out ...
(Date:12/25/2014)... common during the holidays, but there are strategies that can ... arrive at a party hungry. It may seem logical to ... party, but deprivation leads to hunger, and hunger leads to ... Mount Kisco, N.Y., said in a hospital news release. ... to have a snack before attending a party when you ...
(Date:12/25/2014)... 25, 2014 AngelWeddingDress.com tries its best ... online realm. Today, the business has introduced its new ... prom dress promotion. , The new prom outfits are ... every dress lover. They are specially designed for 2015. ... dresses should visit its website before Jan. 26, ...
Breaking Medicine News(10 mins):Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Angelweddingdress 2015 Prom Dresses Online Now 2
... --, -- Management expects to report revenues of approximately, ... the Fiscal Year which ends June 30, 2009. ... approximately $12.4 million and, $1.8 million, respectively., ... $10.5 million in net income, representing approximately 40%, ...
... Hospital Home Health and Hospice Services, the oldest homecare ... entered into a business relationship with Cardiocom (R) ... chronic illness. Cardiocom, the Experts in Telehealth(SM), is ... of award-winning telehealth solutions. , , Cardiocom,s telehealth ...
... , DOYLESTOWN, Pa., June 18 The Quigley Corporation, ... announced that Ted Karkus, Chairman of the Board of The Quigley ... of Directors of the Company. Mr. Karkus will serve in this ... rate of $5,000 per week for his services. , , ...
... NEW YORK , June 18 HLTH Corporation (Nasdaq: ... (Nasdaq: WBMD ), announced today that they have entered ... into WebMD in a tax-free, all-stock transaction. WebMD will be ... serve as Chairman of the Board and Wayne Gattinella will serve ...
... June 18 Multitask Productions LLC is changing the way you ... community featuring dynamic videos of exercises and a content-rich blog designed ... daily routine. , , , From doing ... toned thighs, SqueezeItIn.com shows you how to make fitness fit into ...
... Group, Inc. (Nasdaq: ENSG ), the parent company ... and assisted living companies, announced today that its Board of ... share of Ensign common stock, payable on or before July ... 2009. Ensign has been a dividend-paying company since 2002. ...
Cached Medicine News:Health News:Tianyin Pharmaceutical Co., Inc. Provides Fiscal 2010 Guidance 2Health News:Tianyin Pharmaceutical Co., Inc. Provides Fiscal 2010 Guidance 3Health News:Tianyin Pharmaceutical Co., Inc. Provides Fiscal 2010 Guidance 4Health News:Tianyin Pharmaceutical Co., Inc. Provides Fiscal 2010 Guidance 5Health News:Englewood Hospital Home Health and Hospice Services Selects Cardiocom Telehealth Technology 2Health News:Ted Karkus Appointed Interim Chief Executive Officer Of The Quigley Corporation 2Health News:HLTH Corporation and WebMD Health Corp. Announce Agreement to Merge 2Health News:HLTH Corporation and WebMD Health Corp. Announce Agreement to Merge 3Health News:HLTH Corporation and WebMD Health Corp. Announce Agreement to Merge 4Health News:HLTH Corporation and WebMD Health Corp. Announce Agreement to Merge 5Health News:New Fitness Website Offers a No Gym, No Equipment, No Excuses Workout Solution: SqueezeItIn.com Challenges You to Let Life Be Your Workout 2
Inquire...
...
... is your system. CONMED's family of products ... New, state-of-the art generators feature proprietary Energy ... continuous synchronization of current and voltage in ... enables the system to sample current and ...
... PoliPhase® is a biologically based adhesive ... component system consisting of a liquid ... control of internal bleeding. ... flow on to a prepared wound ...
Medicine Products: